Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

ACI "Paragraph IV Disputes" Conference, New York City, April 30-May 1

By Aaron Barkoff

American Conference Institute will be holding its 2nd annual "Paragraph IV Disputes" conference in New York City next week, April 30 to May 1.  This should be an excellent meeting, with many great speakers on the agenda.

Specific talks of interest include the following:

• Strategic Considerations for the ANDA Applicant's Pre-Litigation Strategy and Initial Obligations
• Rethinking Paragraph IV Challenges in View of Shifting Obviousness Standards
• Litigating with Multiple ANDA Filers: Brand-Name and Generic Perspectives
• View From the Bench: Judicial Views on Paragraph IV Litigation (with three federal judges on the panel)
• Mitigating Antitrust Concerns When Settling a Paragraph IV Action
• Mastering the Interplay Between 180-Day Exclusivity, Forfeiture Provisions and Paragraph IV Litigation
• The Company Perspective on Paragraph IV Disputes: Branded and Generics Views (with in-house counsel from Schering-Plough and Mylan)

In addition, there will be a Master Class on Friday, May 2, entitled "Negotiating and Settling Paragraph IV Disputes: Brand-Name and Generic Perspectives."

For more information or to register, please visit the conference website.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on April 22, 2008 (boomark / email).